1. From the Sam Rothberg Ophthalmic Molecular Biology Laboratory, Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel-Hashomer, Israel;
2. the Laboratory of Neurosciences, Felsenstein Medical Research Center, Tel Aviv University, Petah Tikva, Israel; and
3. the Laboratory of Neurosciences, Felsenstein Medical Research Center, Tel Aviv University, Petah Tikva, Israel; and the 3Norma and Alan Aufzien Chair for Research of Parkinson's Disease, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.